Stader, F.; Sharma, P.; Huang, W.; Choules, M.P.; Willemin, M.-E.; Zhang, X.; Yau, E.; Derbalah, A.; Zyla, A.; Liu, C.;
et al. Physiologically Based Pharmacokinetic Modeling of Biologic Case Studies in Monkeys and Humans Reveals the Necessity of an Additional Clearance Term. Pharmaceutics 2025, 17, 560.
https://doi.org/10.3390/pharmaceutics17050560
AMA Style
Stader F, Sharma P, Huang W, Choules MP, Willemin M-E, Zhang X, Yau E, Derbalah A, Zyla A, Liu C,
et al. Physiologically Based Pharmacokinetic Modeling of Biologic Case Studies in Monkeys and Humans Reveals the Necessity of an Additional Clearance Term. Pharmaceutics. 2025; 17(5):560.
https://doi.org/10.3390/pharmaceutics17050560
Chicago/Turabian Style
Stader, Felix, Pradeep Sharma, Weize Huang, Mary P. Choules, Marie-Emilie Willemin, Xinwen Zhang, Estelle Yau, Abdallah Derbalah, Adriana Zyla, Cong Liu,
and et al. 2025. "Physiologically Based Pharmacokinetic Modeling of Biologic Case Studies in Monkeys and Humans Reveals the Necessity of an Additional Clearance Term" Pharmaceutics 17, no. 5: 560.
https://doi.org/10.3390/pharmaceutics17050560
APA Style
Stader, F., Sharma, P., Huang, W., Choules, M. P., Willemin, M.-E., Zhang, X., Yau, E., Derbalah, A., Zyla, A., Liu, C., & Sepp, A.
(2025). Physiologically Based Pharmacokinetic Modeling of Biologic Case Studies in Monkeys and Humans Reveals the Necessity of an Additional Clearance Term. Pharmaceutics, 17(5), 560.
https://doi.org/10.3390/pharmaceutics17050560